The Frontotemporal Dementia Prevention Initiative: Linking Together Genetic Frontotemporal Dementia Cohort Studies
- 13 January 2021
- book chapter
- Published by Springer Nature
- Vol. 1281, 113-121
Abstract
Around one-third of frontotemporal dementia (FTD) is autosomal dominant with the major genetic causes being mutations in MAPT, GRN and C9orf72. Studying familial forms of FTD can provide a window into the earliest stages of the illness, many years before symptoms start. Large cohort studies have been set up in recent years to better understand this presymptomatic phase, including the Genetic FTD Initiative (GENFI) and the Advancing Research and Treatment for Frontotemporal Lobar Degeneration and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (ARTFL/LEFFTDS) studies. Whilst these studies have focused on the investigation of a variety of aspects of genetic FTD, from understanding the molecular pathogenesis to developing biomarkers, they also have a common goal: finding a way to prevent FTD. Researchers from these cohort studies have therefore come together to form the FTD Prevention Initiative (FPI), which has the overarching aim of promoting clinical trials of new therapies to prevent FTD through creating an international database of participants eligible for trials and uniform standards for conducting such trials. This chapter outlines the work of the FPI so far and its future goals over the next few years.Keywords
This publication has 20 references indexed in Scilit:
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpointAlzheimer's & Dementia, 2020
- 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromesAlzheimer's Research & Therapy, 2019
- Bayesian model of disease progression in GNE myopathyStatistics in Medicine, 2018
- Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross‐sectional diffusion tensor imaging studyAnnals of Clinical and Translational Neurology, 2018
- Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriersAnnals of Clinical and Translational Neurology, 2018
- Neurofilament light chain: a biomarker for genetic frontotemporal dementiaAnnals of Clinical and Translational Neurology, 2016
- Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesNeurology, 2016
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisThe Lancet Neurology, 2015
- Presymptomatic studies in genetic frontotemporal dementiaRevue Neurologique, 2013
- The epidemiology of frontotemporal dementiaInternational Review of Psychiatry, 2013